A Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of Repeated Intravenous Doses of BTT-1023 in Patients With Plaque Psoriasis - a Double-blind Randomized Placebo-controlled Sequential Group Trial.

Trial Profile

A Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of Repeated Intravenous Doses of BTT-1023 in Patients With Plaque Psoriasis - a Double-blind Randomized Placebo-controlled Sequential Group Trial.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Nov 2010

At a glance

  • Drugs Timolumab (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 15 Nov 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
    • 14 Sep 2010 Topline results reported in a Biotie Therapies media release.
    • 14 Sep 2010 Status changed from active, no longer recruiting to completed, according to a Biotie Therapies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top